<DOC>
	<DOCNO>NCT01840735</DOCNO>
	<brief_summary>This study determine safety , tolerability , pharmacokinetics single dose GS-5737 administer 2.8 % saline solution vehicle adult subject CF .</brief_summary>
	<brief_title>Phase 1b Safety , Tolerability , PK Study Assess GS-5737 Subjects With CF</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Males female , ≥ 18 year age , Screening Diagnosis CF determine 1997 CF Consensus Conference criterion , least 1 follow : Documented sweat chloride ≥ 60 mEq/L quantitative pilocarpine iontophoresis test OR Abnormal nasal transepithelial potential difference ( NPD ) test OR Two wellcharacterized , diseasecausing genetic mutation CF transmembrane conductance regulator ( CFTR ) gene AND 1 accompany clinical feature consistent CF FEV1 ≥ 40 % ≤ 90 % predict BMI ≥ 19 ≤ 30 kg/m2 Clinically stable evidence significant new acute respiratory symptom Chest radiograph without significant acute finding ; chest radiograph , CT , MRI obtain interpret within 90 day prior enrollment , without acute finding significant intercurrent illness ; chronic , stable finding allow History lifetime smoke &lt; 5 packyears ( ie , 1 pack per day x 1 year = 1 packyear ) nonsmoker least 60 day duration prior Screening Estimated creatinine clearance ≥ 80 mL/min Screening Negative drug test ; include alcohol Hepatitis B , C , &amp; HIV Negative Surgically sterile ≥ 12 month postmenopausal Nonpregnant female Experienced symptom recent acute upper low respiratory tract infection acute pulmonary exacerbation require treatment within 2 week prior Screening Plasma potassium ≥ 5 mEq/L Changes chronic azithromycin use , bronchodilator ( BD ) , dornase alfa , HS , physiotherapy technique regimen , antibiotic corticosteroid medication within 28 day prior Screening History sputum throat swab culture yield Burkholderia specie within 2 year Screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>CF</keyword>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>PK</keyword>
</DOC>